These authors showed that the expression of DYRK1A mRNA was elevated in the hippocampus of AD patients, coinciding with another report of increased DYRK1A immunoreactivity in the frontal cortex, entorhinal cortex and hippocampus of AD patients [4]. Here, DYRK1A is linked to Alzheimer disease.